Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000215457-19-006721
Filing Date
2019-02-08
Accepted
2019-02-07 18:10:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 us45826j1051_020719.txt SC 13G 11586
  Complete submission text file 0000215457-19-006721.txt   13333
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89486 | Film No.: 19576526
SIC: 2835 In Vitro & In Vivo Diagnostic Substances